Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 68 | 2024 | 4265 | 9.120 |
Why?
|
Graft Rejection | 55 | 2024 | 4492 | 6.490 |
Why?
|
Organ Transplantation | 15 | 2024 | 1178 | 3.370 |
Why?
|
Graft Survival | 27 | 2024 | 3888 | 3.070 |
Why?
|
Facial Transplantation | 10 | 2023 | 222 | 2.940 |
Why?
|
Immunosuppressive Agents | 28 | 2024 | 4207 | 2.900 |
Why?
|
T-Lymphocytes, Regulatory | 21 | 2024 | 3116 | 2.330 |
Why?
|
Kidney Failure, Chronic | 18 | 2024 | 2493 | 2.310 |
Why?
|
Transplantation | 4 | 2024 | 221 | 1.830 |
Why?
|
Proteinuria | 2 | 2024 | 610 | 1.460 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2024 | 86 | 1.450 |
Why?
|
Interleukin-2 | 4 | 2024 | 1895 | 1.300 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2019 | 138 | 1.250 |
Why?
|
Isoantibodies | 6 | 2023 | 681 | 1.210 |
Why?
|
Heart Transplantation | 12 | 2021 | 3301 | 1.120 |
Why?
|
T-Lymphocytes | 15 | 2023 | 10276 | 1.110 |
Why?
|
Immunity, Humoral | 3 | 2022 | 610 | 1.110 |
Why?
|
Transplantation, Homologous | 14 | 2024 | 4835 | 1.080 |
Why?
|
Skin Transplantation | 4 | 2022 | 1097 | 1.030 |
Why?
|
Nephrotic Syndrome | 4 | 2024 | 381 | 1.010 |
Why?
|
Receptors, Notch | 3 | 2020 | 751 | 0.940 |
Why?
|
Living Donors | 4 | 2021 | 649 | 0.900 |
Why?
|
Tissue Donors | 5 | 2022 | 2382 | 0.870 |
Why?
|
Desensitization, Immunologic | 2 | 2022 | 558 | 0.870 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2018 | 1803 | 0.850 |
Why?
|
Tacrolimus | 3 | 2024 | 750 | 0.850 |
Why?
|
Recurrence | 9 | 2024 | 8513 | 0.840 |
Why?
|
Transplantation Immunology | 2 | 2016 | 537 | 0.840 |
Why?
|
Glomerulonephritis | 3 | 2021 | 333 | 0.780 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2228 | 0.780 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 667 | 0.770 |
Why?
|
Kidney Diseases | 6 | 2024 | 2100 | 0.770 |
Why?
|
Postoperative Complications | 13 | 2024 | 15889 | 0.730 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.730 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2024 | 336 | 0.720 |
Why?
|
Immune Tolerance | 7 | 2020 | 2323 | 0.700 |
Why?
|
Th1 Cells | 4 | 2016 | 1042 | 0.660 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2019 | 171 | 0.650 |
Why?
|
Antilymphocyte Serum | 3 | 2022 | 492 | 0.620 |
Why?
|
Immunity, Innate | 3 | 2023 | 3080 | 0.620 |
Why?
|
Brain Death | 1 | 2022 | 359 | 0.620 |
Why?
|
Aptamers, Nucleotide | 1 | 2019 | 163 | 0.610 |
Why?
|
Diet, Gluten-Free | 1 | 2021 | 284 | 0.610 |
Why?
|
Humans | 127 | 2024 | 768970 | 0.590 |
Why?
|
Dairy Products | 1 | 2021 | 490 | 0.580 |
Why?
|
Kidney Tubules, Proximal | 1 | 2019 | 385 | 0.580 |
Why?
|
Chemokines | 1 | 2022 | 963 | 0.580 |
Why?
|
Immunity, Cellular | 3 | 2022 | 1560 | 0.570 |
Why?
|
Antibodies | 3 | 2022 | 2422 | 0.570 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9264 | 0.560 |
Why?
|
Bone Diseases | 1 | 2021 | 416 | 0.560 |
Why?
|
Acute Kidney Injury | 5 | 2021 | 1936 | 0.560 |
Why?
|
Antigens, CD20 | 2 | 2021 | 199 | 0.540 |
Why?
|
Adaptive Immunity | 2 | 2024 | 733 | 0.530 |
Why?
|
Podocytes | 2 | 2021 | 403 | 0.530 |
Why?
|
Cyclosporine | 2 | 2016 | 777 | 0.530 |
Why?
|
Receptor, Notch1 | 1 | 2019 | 520 | 0.520 |
Why?
|
Antigen Presentation | 2 | 2021 | 1252 | 0.520 |
Why?
|
Kidney | 15 | 2024 | 7058 | 0.520 |
Why?
|
Immunocompromised Host | 5 | 2021 | 863 | 0.520 |
Why?
|
Plasmapheresis | 4 | 2022 | 206 | 0.510 |
Why?
|
Lymphocyte Depletion | 2 | 2021 | 605 | 0.500 |
Why?
|
T-Lymphocyte Subsets | 4 | 2021 | 1813 | 0.470 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.460 |
Why?
|
Transplantation, Heterologous | 4 | 2024 | 2395 | 0.460 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4794 | 0.460 |
Why?
|
Blood Proteins | 1 | 2019 | 1191 | 0.460 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1798 | 0.450 |
Why?
|
Mice, Inbred BALB C | 10 | 2020 | 6232 | 0.440 |
Why?
|
Lymphocyte Activation | 7 | 2016 | 5505 | 0.430 |
Why?
|
Interleukin-17 | 3 | 2020 | 925 | 0.430 |
Why?
|
Histocompatibility | 1 | 2014 | 321 | 0.420 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1356 | 0.420 |
Why?
|
Donor Selection | 1 | 2015 | 240 | 0.420 |
Why?
|
Apolipoproteins | 1 | 2015 | 328 | 0.420 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.420 |
Why?
|
Internationality | 1 | 2018 | 1008 | 0.420 |
Why?
|
Computer-Assisted Instruction | 1 | 2016 | 366 | 0.410 |
Why?
|
Immunomodulation | 1 | 2016 | 549 | 0.410 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 301 | 0.410 |
Why?
|
Animals | 41 | 2024 | 169335 | 0.410 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3118 | 0.410 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3241 | 0.400 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.400 |
Why?
|
Signal Transduction | 12 | 2020 | 23653 | 0.400 |
Why?
|
HLA Antigens | 3 | 2022 | 1336 | 0.380 |
Why?
|
Pandemics | 8 | 2020 | 8749 | 0.380 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 373 | 0.370 |
Why?
|
Complement System Proteins | 1 | 2014 | 738 | 0.370 |
Why?
|
Membrane Proteins | 5 | 2021 | 7885 | 0.370 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 986 | 0.370 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 456 | 0.360 |
Why?
|
Autoimmunity | 2 | 2019 | 1360 | 0.360 |
Why?
|
Renal Insufficiency | 2 | 2020 | 812 | 0.360 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 682 | 0.360 |
Why?
|
Immunophenotyping | 2 | 2017 | 1866 | 0.350 |
Why?
|
Drug Resistance | 1 | 2016 | 1599 | 0.350 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3215 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2022 | 2297 | 0.350 |
Why?
|
Hypophosphatemia | 1 | 2011 | 93 | 0.350 |
Why?
|
Withholding Treatment | 1 | 2014 | 620 | 0.340 |
Why?
|
Proteome | 1 | 2019 | 1891 | 0.330 |
Why?
|
Europe | 3 | 2021 | 3441 | 0.330 |
Why?
|
Hepatitis C, Chronic | 2 | 2020 | 1033 | 0.320 |
Why?
|
Steroids | 1 | 2014 | 938 | 0.320 |
Why?
|
Th2 Cells | 3 | 2013 | 1079 | 0.320 |
Why?
|
Interferon-gamma | 2 | 2023 | 3163 | 0.320 |
Why?
|
Fractures, Bone | 1 | 2021 | 2063 | 0.310 |
Why?
|
Mice, Inbred C57BL | 15 | 2020 | 22379 | 0.310 |
Why?
|
Th17 Cells | 4 | 2021 | 791 | 0.310 |
Why?
|
Opportunistic Infections | 3 | 2020 | 375 | 0.310 |
Why?
|
Mice | 25 | 2024 | 82072 | 0.310 |
Why?
|
Immunoconjugates | 3 | 2013 | 976 | 0.300 |
Why?
|
Male | 48 | 2024 | 365203 | 0.300 |
Why?
|
Pilot Projects | 5 | 2024 | 8748 | 0.300 |
Why?
|
Kidney Function Tests | 2 | 2024 | 684 | 0.300 |
Why?
|
Antibody Formation | 2 | 2023 | 1393 | 0.300 |
Why?
|
Neoplasms | 5 | 2022 | 22389 | 0.290 |
Why?
|
Transplantation Tolerance | 2 | 2022 | 633 | 0.290 |
Why?
|
Phosphates | 1 | 2011 | 765 | 0.280 |
Why?
|
Antibodies, Blocking | 3 | 2019 | 250 | 0.280 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 507 | 0.280 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2194 | 0.280 |
Why?
|
Biopsy | 7 | 2024 | 6805 | 0.280 |
Why?
|
Granzymes | 3 | 2022 | 278 | 0.270 |
Why?
|
Thymus Gland | 1 | 2012 | 1266 | 0.270 |
Why?
|
Proteomics | 2 | 2019 | 3914 | 0.270 |
Why?
|
Retrospective Studies | 16 | 2024 | 81903 | 0.270 |
Why?
|
Brazil | 2 | 2021 | 1250 | 0.270 |
Why?
|
Learning | 1 | 2016 | 1760 | 0.270 |
Why?
|
Middle Aged | 29 | 2024 | 223737 | 0.260 |
Why?
|
Female | 44 | 2024 | 397515 | 0.260 |
Why?
|
Interleukin-6 | 2 | 2013 | 3232 | 0.260 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1962 | 0.250 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 977 | 0.250 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4413 | 0.250 |
Why?
|
Autoimmune Diseases | 2 | 2017 | 2258 | 0.250 |
Why?
|
Creatinine | 3 | 2019 | 1917 | 0.240 |
Why?
|
Swine | 4 | 2024 | 5997 | 0.240 |
Why?
|
Inflammation | 5 | 2023 | 10868 | 0.240 |
Why?
|
Dyslipidemias | 1 | 2012 | 873 | 0.240 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2011 | 2893 | 0.230 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2024 | 41 | 0.230 |
Why?
|
Down-Regulation | 1 | 2011 | 2942 | 0.230 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.230 |
Why?
|
Lymphoproliferative Disorders | 2 | 2021 | 529 | 0.230 |
Why?
|
Skin | 4 | 2022 | 4506 | 0.220 |
Why?
|
Placenta | 1 | 2013 | 1725 | 0.220 |
Why?
|
Antiviral Agents | 1 | 2016 | 3070 | 0.220 |
Why?
|
Internet | 1 | 2016 | 3112 | 0.220 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2024 | 106 | 0.220 |
Why?
|
Prospective Studies | 9 | 2024 | 54962 | 0.220 |
Why?
|
Receptors, Phospholipase A2 | 2 | 2021 | 32 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2011 | 3713 | 0.220 |
Why?
|
Treatment Outcome | 14 | 2024 | 65480 | 0.210 |
Why?
|
Calcium | 1 | 2016 | 5792 | 0.210 |
Why?
|
Ligands | 5 | 2022 | 3283 | 0.210 |
Why?
|
Cell Differentiation | 5 | 2024 | 11684 | 0.210 |
Why?
|
Time Factors | 9 | 2021 | 40261 | 0.210 |
Why?
|
Galactosyltransferases | 1 | 2024 | 284 | 0.200 |
Why?
|
Colchicine | 2 | 2021 | 257 | 0.200 |
Why?
|
Adult | 22 | 2024 | 223851 | 0.200 |
Why?
|
Peptides | 2 | 2011 | 4353 | 0.200 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2022 | 126 | 0.190 |
Why?
|
Cytokines | 5 | 2021 | 7453 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2021 | 45 | 0.190 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39394 | 0.190 |
Why?
|
Risk Factors | 12 | 2024 | 74976 | 0.190 |
Why?
|
Nephrology | 2 | 2024 | 270 | 0.180 |
Why?
|
Mycophenolic Acid | 3 | 2024 | 348 | 0.180 |
Why?
|
Prognosis | 6 | 2024 | 30046 | 0.180 |
Why?
|
Chemokines, CC | 1 | 2022 | 286 | 0.180 |
Why?
|
Animals, Genetically Modified | 2 | 2024 | 1564 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3626 | 0.180 |
Why?
|
Organ Preservation | 1 | 2024 | 394 | 0.180 |
Why?
|
Bone Marrow | 1 | 2011 | 2936 | 0.180 |
Why?
|
B-Lymphocyte Subsets | 1 | 2021 | 241 | 0.170 |
Why?
|
Nephritis, Interstitial | 1 | 2021 | 158 | 0.170 |
Why?
|
Glycolysis | 1 | 2024 | 838 | 0.170 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13698 | 0.170 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2019 | 72 | 0.160 |
Why?
|
Minerals | 1 | 2021 | 282 | 0.160 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.160 |
Why?
|
Germinal Center | 1 | 2022 | 380 | 0.160 |
Why?
|
Acute Disease | 4 | 2018 | 7245 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2020 | 4651 | 0.160 |
Why?
|
Mice, Knockout | 7 | 2013 | 14484 | 0.160 |
Why?
|
Hyperparathyroidism | 1 | 2020 | 339 | 0.160 |
Why?
|
Patient Selection | 2 | 2022 | 4265 | 0.160 |
Why?
|
Aged | 17 | 2024 | 171786 | 0.160 |
Why?
|
Incidence | 6 | 2024 | 21547 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 281 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4428 | 0.160 |
Why?
|
Crystallization | 1 | 2019 | 520 | 0.160 |
Why?
|
Hypokalemia | 1 | 2019 | 152 | 0.160 |
Why?
|
Hyperammonemia | 1 | 2019 | 80 | 0.150 |
Why?
|
STAT5 Transcription Factor | 1 | 2019 | 268 | 0.150 |
Why?
|
Integrin alpha Chains | 1 | 2018 | 93 | 0.150 |
Why?
|
Retreatment | 1 | 2020 | 600 | 0.150 |
Why?
|
Quality of Life | 2 | 2021 | 13510 | 0.150 |
Why?
|
Peri-Implantitis | 1 | 2020 | 124 | 0.150 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6320 | 0.150 |
Why?
|
Remission Induction | 2 | 2024 | 2408 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2022 | 2574 | 0.150 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 690 | 0.150 |
Why?
|
Transplants | 1 | 2020 | 209 | 0.150 |
Why?
|
Survival Analysis | 2 | 2021 | 10115 | 0.150 |
Why?
|
Cyclophosphamide | 2 | 2021 | 2227 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 329 | 0.140 |
Why?
|
Paraproteinemias | 1 | 2019 | 252 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4064 | 0.140 |
Why?
|
North America | 1 | 2020 | 1290 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9549 | 0.130 |
Why?
|
Blogging | 1 | 2016 | 15 | 0.130 |
Why?
|
Up-Regulation | 2 | 2018 | 4148 | 0.130 |
Why?
|
Risk Assessment | 7 | 2024 | 24333 | 0.130 |
Why?
|
Autoantibodies | 2 | 2021 | 2120 | 0.130 |
Why?
|
Reperfusion | 1 | 2017 | 266 | 0.130 |
Why?
|
Antigens, CD | 3 | 2018 | 4032 | 0.130 |
Why?
|
Replantation | 1 | 2017 | 145 | 0.130 |
Why?
|
Serpins | 2 | 2017 | 246 | 0.130 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18354 | 0.130 |
Why?
|
Amputation, Traumatic | 1 | 2017 | 135 | 0.130 |
Why?
|
Albuminuria | 1 | 2019 | 658 | 0.130 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9565 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 1240 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 2 | 2024 | 1892 | 0.120 |
Why?
|
Death | 1 | 2019 | 683 | 0.120 |
Why?
|
Chronic Disease | 4 | 2018 | 9384 | 0.120 |
Why?
|
Renal Replacement Therapy | 1 | 2017 | 282 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1855 | 0.120 |
Why?
|
Flow Cytometry | 4 | 2013 | 5906 | 0.110 |
Why?
|
Hypoparathyroidism | 1 | 2015 | 136 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2022 | 1163 | 0.110 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2013 | 58 | 0.110 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 433 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
Dysuria | 1 | 2013 | 6 | 0.110 |
Why?
|
Teriparatide | 1 | 2015 | 226 | 0.110 |
Why?
|
Parathyroidectomy | 1 | 2015 | 244 | 0.110 |
Why?
|
Adoptive Transfer | 2 | 2013 | 824 | 0.110 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.110 |
Why?
|
Cells, Cultured | 4 | 2019 | 19023 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2009 | 0.110 |
Why?
|
Face | 1 | 2019 | 1031 | 0.100 |
Why?
|
Complement Inactivating Agents | 2 | 2024 | 53 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 429 | 0.100 |
Why?
|
Models, Immunological | 2 | 2013 | 518 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2024 | 5864 | 0.100 |
Why?
|
Homeostasis | 2 | 2014 | 3347 | 0.100 |
Why?
|
Mice, Inbred CBA | 1 | 2013 | 438 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2021 | 2063 | 0.100 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 117 | 0.100 |
Why?
|
Intestines | 1 | 2021 | 1911 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1965 | 0.100 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1439 | 0.100 |
Why?
|
Histocompatibility, Maternal-Fetal | 1 | 2011 | 9 | 0.100 |
Why?
|
Histocompatibility Antigens | 1 | 2013 | 479 | 0.100 |
Why?
|
United States | 6 | 2024 | 73186 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2017 | 756 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3629 | 0.100 |
Why?
|
Extremities | 1 | 2017 | 870 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2018 | 2732 | 0.090 |
Why?
|
Immunologic Factors | 2 | 2021 | 1597 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1626 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 662 | 0.090 |
Why?
|
Calcium Compounds | 1 | 2011 | 40 | 0.090 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1705 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 696 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8055 | 0.090 |
Why?
|
Complement C3 | 2 | 2024 | 434 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 369 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 122 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2016 | 1378 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1891 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2016 | 1320 | 0.090 |
Why?
|
Cause of Death | 2 | 2018 | 3721 | 0.090 |
Why?
|
Apoptosis | 3 | 2022 | 9527 | 0.090 |
Why?
|
Growth Inhibitors | 1 | 2011 | 375 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1811 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2018 | 2748 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5323 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1755 | 0.080 |
Why?
|
Lipids | 1 | 2021 | 3345 | 0.080 |
Why?
|
Survival Rate | 1 | 2024 | 12873 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3438 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 317 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1151 | 0.080 |
Why?
|
Kidney Glomerulus | 1 | 2011 | 569 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1902 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10592 | 0.080 |
Why?
|
Publishing | 1 | 2016 | 837 | 0.080 |
Why?
|
Young Adult | 6 | 2021 | 60131 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1737 | 0.080 |
Why?
|
Ischemia | 1 | 2017 | 1900 | 0.080 |
Why?
|
Cell Polarity | 1 | 2011 | 639 | 0.080 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 1027 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 797 | 0.070 |
Why?
|
Canada | 2 | 2023 | 2130 | 0.070 |
Why?
|
Rabbits | 1 | 2014 | 4774 | 0.070 |
Why?
|
Forecasting | 1 | 2017 | 2945 | 0.070 |
Why?
|
Bone Density | 1 | 2021 | 3574 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7460 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 609 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13021 | 0.070 |
Why?
|
Spleen | 1 | 2013 | 2294 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2014 | 984 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1794 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2474 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2017 | 2241 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20245 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15951 | 0.070 |
Why?
|
Child, Preschool | 4 | 2021 | 42683 | 0.070 |
Why?
|
Genotype | 2 | 2024 | 13048 | 0.070 |
Why?
|
Prednisone | 2 | 2021 | 1567 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 873 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6512 | 0.060 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 822 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3683 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1619 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18435 | 0.060 |
Why?
|
Brain | 2 | 2022 | 27453 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2016 | 1470 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3838 | 0.060 |
Why?
|
Boston | 2 | 2014 | 9377 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6547 | 0.050 |
Why?
|
Complement C4b | 1 | 2023 | 124 | 0.050 |
Why?
|
Child | 5 | 2024 | 80960 | 0.050 |
Why?
|
Adolescent | 5 | 2024 | 89244 | 0.050 |
Why?
|
Administration, Oral | 1 | 2011 | 4040 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11116 | 0.050 |
Why?
|
Focal Adhesions | 1 | 2023 | 114 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2022 | 208 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9621 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8559 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10765 | 0.050 |
Why?
|
Models, Animal | 2 | 2024 | 2122 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8384 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.050 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2022 | 100 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2013 | 3473 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5544 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11932 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 808 | 0.050 |
Why?
|
Coronary Disease | 1 | 2015 | 5919 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2020 | 135 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6611 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2022 | 692 | 0.040 |
Why?
|
Azathioprine | 1 | 2021 | 354 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2021 | 564 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1402 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 794 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 235 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 734 | 0.040 |
Why?
|
Infant | 1 | 2021 | 36556 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18068 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1298 | 0.040 |
Why?
|
Methylprednisolone | 1 | 2020 | 386 | 0.040 |
Why?
|
Vincristine | 1 | 2021 | 1040 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3408 | 0.040 |
Why?
|
Ritonavir | 1 | 2020 | 332 | 0.040 |
Why?
|
Italy | 1 | 2020 | 856 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 153 | 0.040 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 192 | 0.040 |
Why?
|
Erythema | 1 | 2019 | 261 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 437 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3253 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59739 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2021 | 1789 | 0.030 |
Why?
|
Heart Failure | 1 | 2021 | 11879 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3447 | 0.030 |
Why?
|
Nephrectomy | 1 | 2021 | 949 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6569 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14201 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15471 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 745 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 378 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2020 | 753 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 840 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
Acute Coronary Syndrome | 1 | 2008 | 2194 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4356 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2021 | 617 | 0.030 |
Why?
|
Exanthema | 1 | 2019 | 503 | 0.030 |
Why?
|
Doxorubicin | 1 | 2021 | 2234 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 874 | 0.030 |
Why?
|
Immunotherapy | 2 | 2020 | 4756 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1436 | 0.030 |
Why?
|
Pregnancy | 2 | 2013 | 30265 | 0.030 |
Why?
|
Amyloidosis | 1 | 2021 | 879 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2020 | 1803 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11521 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2089 | 0.030 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 839 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2205 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2884 | 0.030 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 381 | 0.020 |
Why?
|
Dental Implants | 1 | 2020 | 807 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2011 | 120 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3214 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1445 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2011 | 217 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4568 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 422 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6901 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 412 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 825 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 606 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3592 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2013 | 1207 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2010 | 1163 | 0.020 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 921 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 892 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3591 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3968 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2012 | 1157 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 756 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41808 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 962 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1145 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1973 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2336 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1839 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1083 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2784 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1026 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2631 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1728 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12806 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2020 | 4363 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5033 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2017 | 3800 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10400 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2015 | 4541 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2046 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5369 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5716 | 0.010 |
Why?
|
Lung Transplantation | 1 | 2010 | 1309 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 973 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10847 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10486 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2911 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2013 | 3048 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11886 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17173 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9344 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12095 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13318 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14752 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23786 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7478 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20776 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26395 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15661 | 0.000 |
Why?
|